Dihydrofolate Reductase Inhibitor Antibacterial
43 drugs across 19 manufacturers|43 Generic,0 Brand
The Dihydrofolate Reductase Inhibitor Antibacterial class contains 43 NDCs from 19 manufacturers (43 generic, 0 brand), at an average NADAC of $0.17 per unit. Every drug, manufacturer, and price in this FDA-defined pharmacologic class is listed below.
Total Drugs
43
43G / 0B
Manufacturers
19
Avg $0.1714/unit
Avg 7d Change
+2.84%
Across 31 drugs with changes
7d Activity
of 43 total drugs
Class Price Trend
Monthly average NADAC price per unit, split by generic and brand
Manufacturer Breakdown
19 manufacturers producing drugs in this therapeutic class(3 pricing outliers)
and 7 more manufacturers
Follow this class across the site
These links connect the therapeutic class page to the specific suppliers, markets, and trend surfaces that help users keep exploring.
Top supplier
Chartwell RX LLC manufacturer profile
Review the supplier with the strongest product footprint inside this therapeutic class.
Lead market
Sulfamethoxazole and Trimethoprim market page
Move from the therapeutic class into the molecule that appears most often in this class-specific portfolio.
Trend hub
Latest trend hub
Compare this class against the rest of the weekly NADAC trend surface.
Guide
Understanding NADAC pricing
Use the explainer when you need a plain-English refresher on how these class-level numbers are published and interpreted.
Frequently Asked Questions
How many drugs are in the Dihydrofolate Reductase Inhibitor Antibacterial class?
The Dihydrofolate Reductase Inhibitor Antibacterial class contains 43 NDCs from 19 manufacturers — 43 generic and 0 brand products.
What is the average price of Dihydrofolate Reductase Inhibitor Antibacterial drugs?
The average NADAC for the Dihydrofolate Reductase Inhibitor Antibacterial class is $0.1714 per unit across 43 NDCs.
Which manufacturers make Dihydrofolate Reductase Inhibitor Antibacterial drugs?
19 manufacturers make drugs in the Dihydrofolate Reductase Inhibitor Antibacterial class. Ranked by number of NDCs, the largest are Chartwell RX LLC (5), Aurobindo Pharma Limited (5), Vista Pharmaceuticals, Inc. (4), Amneal Pharmaceuticals of New York LLC (4), Sun Pharmaceutical Industries Inc. (4).
How has Dihydrofolate Reductase Inhibitor Antibacterial pricing changed recently?
Over the past 7 days, 21 NDCs in this class rose and 10 fell, with a class-wide average change of +2.8%.